PRINCETON - PDS Biotechnology Corporation (NASDAQ:PDSB) has confirmed plans to commence its VERSATILE-003 Phase 3 clinical trial for a promising cancer immunotherapy within the first quarter of 2025.

We see weather headlines year round from winter to severe weather in the summer, but there is a set hierarchy to them.

In anticipation of the release of their highly awaited 22-track album, “No Song Hold On,” PDS has released another ...

A PDS gang member named Isjalon Jermiah Armstead has pled guilty to firing a weapon during a "rolling shootout" linked to ...

Blue Trust Inc. increased its stake in shares of Precision Drilling Co. (NYSE:PDS – Free Report) (TSE:PD) by 64.7% in the ...

Precision Drilling (NYSE:PDS – Get Free Report) (TSE:PD) is expected to release its earnings data before the market opens on ...

Robbinsville boys basketball advances past Princeton Day in the CVC Tournament with a clutch second half to set up a quarterfinal game at WW-P North ...

The Navy has awarded various contracts relating to the Independence-variant Littoral Combat Ship’s mine countermeasures mission package, all preceding an anticipated rollout of the package on the LCS ...

The February 2025 issue of Radio Ink Magazine is packed with content that will encourage you and your team to prospect, ...

Companies in the Energy sector have received a lot of coverage today as analysts weigh in on Pyxis Tankers (PXS – Research Report), Strike ...

In the upcoming CRS issue of Radio Ink Magazine, we delve into how the Top Country Radio PDs in America view AI's role at ...

South Africa’s pioneering role in proximity detection systems (PDS) has created opportunities for Booyco Electronics to ...